Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.68 USD | -6.60% | -8.46% | -54.79% |
May. 28 | RBC Halves Price Target on Verastem to $16 From $32, Maintains Outperform Rating, Speculative Risk Qualifier | MT |
May. 24 | Top Midday Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-54.79% | 99.78M | |
+16.73% | 121B | |
+13.04% | 107B | |
-5.80% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.00% | 15.31B | |
+1.18% | 14.08B | |
+24.18% | 11.74B |
- Stock Market
- Equities
- VSTM Stock
- News Verastem, Inc.
- Verastem Partners With GenFleet Therapeutics to Advance Oncology Discovery Programs